3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
6
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Prostatic Neoplasms
26
Lymphoma, Large B-Cell, Diffuse
17
Burkitt Lymphoma
11
Precursor Cell Lymphoblastic Leukemia-Lymphoma
10
Lymphoma, T-Cell, Peripheral
8
Lymphoma, Follicular
8
Lymphoma, B-Cell
7
Lymphoma
6
Neoplasms
5
Lymphoma, Non-Hodgkin
4
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
3
Neoplasm Metastasis
3
Leukemia, Biphenotypic, Acute
3
Recurrence
2
Prostatic Neoplasms, Castration-Resistant
2
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
2
Plasmablastic Lymphoma
2
Ovarian Neoplasms
2
Myasthenia Gravis
2
Lymphoma, T-Cell
2
Lymphoma, Mantle-Cell
2
Lymphoma, B-Cell, Marginal Zone
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Leukemia
2
Endometrial Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Urogenital Neoplasms
1
Triple Negative Breast Neoplasms
1
Stomach Neoplasms
1
Prostatic Diseases
1
Interventions
Cyclophosphamide
10
fludarabine
6
Tacrolimus
5
Mycophenolic Acid
5
Melphalan
4
ruxolitinib
3
Whole-Body Irradiation
3
Thiotepa
3
Busulfan
3
thymoglobulin
2
fludarabine phosphate
2
Stem Cell Transplantation
2
Specimen Handling
2
Clofarabine
2
Biopsy
2
vedolizumab
1
belumosudil
1
Tomography, Optical Coherence
1
Sirolimus
1
Radiotherapy
1
Radiation
1
Prednisone
1
Methotrexate
1
Mesna
1
Low-Level Light Therapy
1
LDP-02
1
Immunoglobulin G
1
Hematopoietic Stem Cell Transplantation
1
Fecal Microbiota Transplantation
1
Emapalumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Graft vs Host Disease
×
Prednisone
×
Clear all
NCT06756061
2025-02-19
FRONTJAK-001
Seoul St. Mary's Hospital
Phase 2
Recruiting
88 enrolled